Grant Analysis Report

Powered by GrantArchive

Detailed Analysis

Overall
65
C
SEO
70
25%
Performance
65
25%
Mobile
75
15%
Security
80
20%
seo
70
performance
65
mobile
75
security
80

SEO Analysis

Title Tag

Length: 108 characters (Optimal: 40-60)

Meta Description

Length: 160 characters (Optimal: 120-160)

H1 Headings

Found: 1 H1 tag

Heading Hierarchy

H1: 1, H2: 4, H3: 3

PageSpeed Insights (Placeholder)

Desktop Score 91
Mobile Score 73

* Placeholder data. Integrate PageSpeed Insights API for real metrics.

Meta Tags Analysis

Tag Status Details
TitleGood108 chars
DescriptionGood160 chars
H1Present1 found
H2-H6Present3 headings

Image Analysis

Alt Tags
Missing: 0 / Total: 1
File Sizes
Optimized: Yes
WebP Usage
Enabled
Lazy Loading
Implemented

Link Analysis

7
Total Links
3
Internal
5
External
0
Broken
Note: Broken link checking requires external API integration

Mobile-Friendliness

Viewport Set

Width=device-width, initial-scale=1

Mobile Friendly

Page passes mobile-friendly test

Tap Targets

Adequate spacing between links

Font Size

Readable without zooming

SSL/TLS Certificate

Status
Valid
Issuer
Let's Encrypt
Grade
A+

Security Headers

Header Status Grade
HSTSPresentA
CSPPresentA
X-Frame-OptionsPresentA
X-Content-TypePresentA
Referrer-PolicyPresentA
Permissions-PolicyMissingC

Technology Stack

CMS/Framework
Symfony
Server
Nginx
PHP Version
8.3
Database
PostgreSQL

DNS Records (Placeholder)

A Record
172.16.0.1
MX
mail.example.com
NS
ns1.example.com

* DNS data requires external API integration

WHOIS Data (Placeholder)

Registrar
Example Registrar
Registration Date
2020-01-01
Expiry Date
2027-01-01
Days Until Expiry
352

* WHOIS data requires external API integration

Core Web Vitals

LCP
2002ms
Needs Improvement
FID/INP
70ms
Good
CLS
0.000
Good
FCP
1427ms
Good

* Placeholder values. Integrate PageSpeed Insights API for real Core Web Vitals data.

How GrantArchive Scoring Works

1. Data Analysis

We analyze grant data directly from Grants.gov including funding amounts, eligibility, and historical patterns.

2. Score Calculation

Our algorithm scores each grant on funding potential, urgency, competition level, and match quality.

3. Get Notified

Set up alerts to never miss a deadline and receive personalized recommendations.

Advertisement
Open · 74 days left D National Institutes of Health

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

Funding
Not specified
Deadline
--
Days
--
Hrs
--
Min
--
Sec
May 07, 2026
Posted Nov 18, 2024 (460 days ago)
Closes May 7, 2026 (in 74 days)

Grant Details

Opportunity Number
PAR-25-110
CFDA / ALN
93.242, 93.279, 93.313, 93.855, 93.865
Opportunity Category
Discretionary (D)
Funding Category
ED, HL, ISS
Funding Instrument
Grant (G)
Cost Sharing
No Cost Sharing (No)

Eligibility

State governments (00) County governments (01) City or township governments (02) Special district governments (04) Independent school districts (05) Public and State controlled institutions of higher education (06) Native American tribal governments (Federally recognized) (07) Public housing authorities / Indian housing authorities (08) Native American tribal organizations (11) Nonprofits having a 501(c)(3) status with the IRS (12) Nonprofits without 501(c)(3) status (13) Private institutions of higher education (20) For-profit organizations other than small businesses (22) Small businesses (23) Others (25)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Description

The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating women, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating women, fetuses, neonates, and children, including those with disabilities.
Loading…
Loading the web debug toolbar…
Attempt #